dapa hf dapa ckd #dapackdtrial #sglt2idapa #pcmanoria
Published 3 years ago • 3.8K plays • Length 42:28Download video MP4
Download video MP3
Similar videos
-
2:53
dapa ckd trial
-
6:11
dapa-ckd: does confirmed renoprotection make the case for first-line sglt2 inhibition? | luigi gnudi
-
3:08
dapa trial
-
9:32
dapa ckd - trial
-
14:44
dapa-ckd by amr el-husseini
-
4:28
dapa-hf: substudy shows dapagliflozin reduces t2d risk in hf
-
2:56
dapa hf trial
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
7:32
dapa-hf clinical trial i dapagliflozin i hfref
-
8:14
dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
-
2:12
dapa-ckd discussion - manesh patel, md
-
4:17
esc 2020: commentary on the dapa-ckd study — dr giuseppe galati
-
4:46
hfa 23: dapa-hf and deliver: kccq in patients with varying ejection fraction
-
7:38
dapa ckd
-
9:06
sglt2 inhibitors in chronic kidney disease
-
3:21
esc tv at esc congress 2020 - dapa-ckd (investigator)
-
1:22
dr john mcmurray details the preliminary cost-effectiveness distinction of dapagliflozin
-
3:30
researcher comment: the dapa-hf trial | john mcmurray
-
5:41
kieran docherty, mbchb: impact of t2d background therapy on dapagliflozin benefit